Chen Lien Dong from Oakland, CA, age 51

Resumes

Associate

View page

Location:

Malden, MA

Industry:

Financial Services

Work:

Svb Financial Group
Associate
Boston Digital Ventures Sep 2016 - Dec 2016
Intern
Brandeis International Business School Aug 2016 - Dec 2016
Advanced Teaching Assistant
China Citic Bank Jul 2013 - May 2014
Account Associate and Assistant To Branch President
China Construction Bank Jul 2012 - Aug 2012
Corporate Banking Department Intern

Education:

Brandeis University 2015 - 2016
Masters, Finance Guangdong University of Foreign Studies 2009 - 2013
Bachelors, Economics, Finance Guangdong Experimental High School

Skills:

Customer Service
Management
Research
Microsoft Office
Microsoft Excel
Project Management
Leadership
Microsoft Word
Powerpoint
Public Speaking
Matlab
Visual Basic For Applications
Bloomberg
Capital Iq

Interests:

Social Services
Education

Languages:

English
Mandarin
Cantonese

Certifications:

Cfa Level Ii Candidate
Frm Level I Candidate
License Level Ii Candidate

Research Assistant

View page

Location:

San Francisco, CA

Industry:

Hospital & Health Care

Work:

Usda-Ars
Research Assistant
Usda-Ars Jun 2013 - Aug 2013
Research Scientist Intern
Beijing Mercedes-Benz Sales Service Co. Ltd Oct 2010 - Jul 2011
Price and Sales Controlling Intern

Education:

Renmin University of China 2007 - 2011
Bachelor of Engineering, Bachelors, Management

Skills:

Polymer Science
Project Management
Data Analysis
Rt Pcr
Pcr Primer Design
Dna Extraction
Tissue Culture
Rna Isolation
Gpc
Market Research
Pricing
Java
C
Web Design
Finance

Interests:

Health

Languages:

English
Mandarin

Senior Scientist

View page

Location:

835 Betlin Ave, Cupertino, CA 95014

Industry:

Pharmaceuticals

Work:

Anacor Pharmaceuticals May 2008 - Jun 2011
Research Scientist Iii
Anacor Pharmaceuticals May 2008 - Jun 2011
Senior Scientist
Roche Jan 2007 - May 2008
Research Scientist

Education:

Stanford University School of Medicine 2002 - 2007
Associates, Immunology Stanford University School of Medicine 2000 - 2002
Indiana University Bloomington 1996 - 2000
Doctorates, Doctor of Philosophy, Biology

Skills:

Drug Discovery
Biotechnology
Molecular Biology
Drug Development
Biochemistry
Immunology
Assay Development
Pharmaceutical Industry
Lifesciences
Cell Culture
Elisa
Cell
Clinical Development
Life Sciences
Biomarkers

Languages:

English

Chen Dong

View page

Location:

Washington, DC

Industry:

Computer Software

Work:

Adobe
Manager, Data Science
Adobe 2014 - 2016
Data Scientist
University of Maryland 2010 - 2014
Research Assistant
Liberty Mutual Insurance Jun 2013 - Aug 2013
Statistician Intern -- Predictive Modeling
Adobe Jun 2013 - Aug 2013
Manager, Data Science, Adobe

Skills:

Python
Development
Data Analysis
Optimization
R
Software Development
Machine Learning
Statistical Modeling
C++
Sas
Predictive Modeling

R And D Engineer Senior

View page

Location:

San Francisco, CA

Industry:

Semiconductors

Work:

Magma Design Automation Jul 2010 - May 2012
Senior Technical Staff
Synopsys Jul 2010 - May 2012
R and D Engineer Senior

Education:

University of Illinois at Urbana - Champaign 2006 - 2010
Doctorates, Doctor of Philosophy, Computer Engineering

Skills:

C++
Eda
Verilog
Algorithms
Soc
Asic
C
Field Programmable Gate Arrays
System on A Chip
Perl

Chen Dong

View page

Chen Dong

View page

Chen Dong

View page

Business Records

Name / Title

Company / Classification

Phones & Addresses

Chen Dong
Manager

Delon Scientific Instrument LC

Chen Wei Dong
Director, President, Secretary

China Changjiang Mining & New Energy Co., Ltd

News

China plans to complete space station with latest mission

View page

Commander Chen Dong and fellow astronauts Liu Yang and Cai Xuzhe will assemble the three-module structure joining the existing Tianhe with Wentian and Mengtian, due to arrive in July and October. Another cargo craft, the Tianzhou-3, remains docked with the station.

Date

Jun 04, 2022

Category:

U.S.

Source:

Google

After recovering from COVID-19, are you immune?

View page

For example, a study led by researcher Chen Dong of the Institute for Immunology and the School of Medicine at Tsinghua University in Beijing analyzed the blood of 14 COVID-19 patients who had experienced relatively mild COVID-19 symptoms 14 days after discharge from the hospital. They found that 13

Date

May 11, 2020

Category:

More news

Source:

Google

China's Space Plans: First Chinese Cargo Spacecraft Will Lift Off In April

View page

In October 2016, the Tiangong-2 was used to carry out China's longest manned mission in space, sending two astronauts to live aboard the space laboratory for a month. Chinese astronauts Jing Haipeng and Chen Dong returned to Earth on Nov. 18 after spending 30 days in orbit inside the Tiangong-2 spac

Date

Feb 14, 2017

Source:

Google

China Announces Plans for Moon and Mars Missions

View page

Tiangong-1 is now in a decaying orbit and has been replaced by Tiangong-2, which was most recently visited by taikonauts Jing Haipeng and Chen Dong on the Shenzhou 11 mission for 30 days, the longest Chinese spaceflight in history. These prototype space laboratories act as test beds and pave the way

Date

Dec 27, 2016

Category:

Sci/Tech

Source:

Google

China's Shenzhou 11 manned space capsule returns to Earth

View page

The two astronauts, Jing Haipeng and Chen Dong, spent 30 days aboard the Tiangong 2 space laboratory, or "Heavenly Palace 2", which China is using to carry out experiments ahead of a longer-range plan to have a permanent manned space station around 2022.

Date

Nov 18, 2016

Category:

Sci/Tech

Source:

Google

Chinese astronauts land after record mission

View page

Recovery crews surrounded the descent module after landing, quickly opening its upper hatch. Chinese television cut away from the landing site before commander Jing Haipeng and flight engineer Chen Dong were extracted, but mission managers reported the crew was healthy.

Date

Nov 18, 2016

Source:

Google

Why the Shenzhou 11 landing is another leap forward for China

View page

The taikonauts, Jing Haipeng and Chen Dong, returned after 30 days aboard the Tiangong 2 space laboratory (translated as "Heavenly Palace") in low Earth orbit, where they tested its habitability and conducted scientific and medical experiments.

Date

Nov 18, 2016

Category:

Sci/Tech

Source:

Google

[ November 18, 2016 ] Two Chinese astronauts back on Earth Mission Reports

View page

Jing Haipeng, the mission commander, wrapped up his third mission after setting the record for the most cumulative time in space by a Chinese citizen with 47 days. Crewmate Chen Dong concluded his first spaceflight.

Date

Nov 18, 2016

Category:

Sci/Tech

Source:

Google

Publications

Wikipedia References

Chen Dong (Footballer)

Chen Dong (General)

Chen Dong (Taikonaut)

Us Patents

Cd80 Variant Proteins And Uses Thereof

View page

US Patent:

20220227833, Jul 21, 2022

Filed:

Apr 24, 2020

Appl. No.:

17/606577

Inventors:

- Shijiazhuang, CN
- Beijing, CN
Yi DING - Milpitas CA, US
Ping Hui SZU - Walnut Creek CA, US
Chen DONG - Cupertino CA, US

International Classification:

C07K 14/705
A61P 35/00

Abstract:

The present disclosure provides variant CD80 polypeptides that have altered affinity for their cognate binding partners, and immunomodulatory fusion proteins comprising the variant CD80 polypeptides. The present disclosure also provides pharmaceutical compositions comprising such polypeptides and/or proteins and methods for modulating immune responses and/or treatment of cancer, infectious diseases, and/or immunological diseases.

Anti-Claudin 18.2 Antibodies

View page

US Patent:

20210009686, Jan 14, 2021

Filed:

Mar 14, 2019

Appl. No.:

16/980294

Inventors:

- Beijing, CN
Yi DING - Milpitas CA, US
Chen DONG - Cupertino CA, US
Zhiwei LI - West Sacramento CA, US
John LIPPINCOTT - San Mateo CA, US
Ping Hui SZU - Walnut Creek CA, US

International Classification:

C07K 16/28
A61K 39/395
G01N 33/68
A61K 45/06
A61P 35/00

Abstract:

Provided are anti-claudin 18.2 (CLDN18.2) antibodies and fragments thereof. Also provided are isolated nucleic acid molecules that encode anti-CLDN18.2 antibodies, vectors comprising such nucleic acid, and host cells comprising such vectors or nucleic acids. Provided are methods of making anti-CLDN18.2. Also provided are related pharmaceutical compositions and methods using such pharmaceutical compositions in the treatment of disorders associated with aberrant CLDN18.2 expression, such as cancers.